In the 21st century, humanity has been pushing the boundaries of what is possible. Creating medicine tailored to an individual’s genetic makeup is just one of many topics that is both controversial and beneficial to society.
I believe personalized medicine presents numerous opportunities, as it will help healthcare address infections and diseases at a genetic level. This can significantly decrease the fatality rates of diseases such as the Nipah virus and tuberculosis among both children and adults.
However, there are several challenges related to this issue that arise from social and economic perspectives. In an ideal world, personalized medicine would be distributed to the general public at no cost. Unfortunately, capitalistic pharmaceutical companies often price personalized medicine beyond the reach of the average middle-class individual. This situation exacerbates the disparity between the rich and the poor, positively affecting the wealthy while adversely impacting the less affluent, leading to a decline in living standards and increasing mortality rates from both existing and emerging diseases.
In my opinion, personalized medicine is crucial for the survival of the human race. The future is uncertain, with the emergence of new diseases and crises that we have yet to confront. Personalized medicine has the potential to help us address these challenges; however, issues related to pricing must be tackled. Once released into the open market, the rarity of these products will likely drive prices up. A viable solution to prevent price gouging would be for the government to implement price ceilings and provide subsidies for those who cannot afford it. By adopting this strategy, we can ensure that personalized medicine is accessible to everyone.